dc.contributor.author |
Wang, Zhen |
en |
dc.contributor.author |
Wu, Zimei |
en |
dc.contributor.author |
Liu, Jianping |
en |
dc.contributor.author |
Zhang, Wenli |
en |
dc.date.accessioned |
2018-12-09T23:48:20Z |
en |
dc.date.issued |
2018-04 |
en |
dc.identifier.issn |
1742-5247 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/44922 |
en |
dc.description.abstract |
INTRODUCTION:Efficient delivery of drugs by nanoparticles deep into solid tumors is the precondition of valid cancer therapy. Despite profound understanding of the delivery of spherical nanoparticles into solid tumor attained, insufficient attention was paid to anisotropic particles. Actually, owing to their structural asymmetry, some non-spherical particles exhibit significant advantages over their spherical counterparts. AREAS COVERED:This review will focus on particles with different shapes (discoidal particle, nanorod, filamentous particle, single-walled carbon nanotube) and the influence of their morphological characteristics (size, aspect ratio, rigidity) on the process of drug delivery to solid tumor in view of systemic circulation, transport from circulation system to tumor tissue, intratumoral transport and uptake by tumor cells, on the basis of introduction of challenges for drug delivery to solid tumor. In addition, the morphological characteristics will be briefly introduced to provide an understanding of anisotropic particle morphology. EXPERT OPINION:Anisotropic particles exhibit desirable properties such as enhanced circulation time and efficient tumor penetration that could serve as an enlightenment in the exploitation of novel non-spherical nanocarriers to clinical therapy. Yet, current understanding of how anisotropic particles interact with organism is insufficient, which restricts the biomedical application of anisotropic particles. Further work is desired for the development of practical fabrication of anisotropic particles, quantitative analysis of particle morphology, as well as profound understanding of new targeting mechanism and intratumoral penetration of anisotropic particles. |
en |
dc.format.medium |
Print-Electronic |
en |
dc.language |
eng |
en |
dc.relation.ispartofseries |
Expert opinion on drug delivery |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.subject |
Animals |
en |
dc.subject |
Humans |
en |
dc.subject |
Neoplasms |
en |
dc.subject |
Antineoplastic Agents |
en |
dc.subject |
Drug Delivery Systems |
en |
dc.subject |
Biological Transport |
en |
dc.subject |
Anisotropy |
en |
dc.subject |
Particle Size |
en |
dc.subject |
Nanoparticles |
en |
dc.title |
Particle morphology: an important factor affecting drug delivery by nanocarriers into solid tumors. |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.1080/17425247.2018.1420051 |
en |
pubs.issue |
4 |
en |
pubs.begin-page |
379 |
en |
pubs.volume |
15 |
en |
dc.rights.holder |
Copyright: The author |
en |
dc.identifier.pmid |
29264946 |
en |
pubs.end-page |
395 |
en |
pubs.publication-status |
Published |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Research Support, Non-U.S. Gov't |
en |
pubs.subtype |
Review |
en |
pubs.subtype |
Journal Article |
en |
pubs.elements-id |
719780 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
Pharmacy |
en |
dc.identifier.eissn |
1744-7593 |
en |
pubs.record-created-at-source-date |
2017-12-22 |
en |
pubs.dimensions-id |
29264946 |
en |